nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
68 A bayesian approach to modeling the relation between treatment benefit and underlying risk in meta-analysis
|
Sharp, Stephen |
|
1997 |
18 |
3S1 |
p. S83- 1 p. |
artikel |
2 |
81 A data management system allowing multi-institutional clinical trials to deliver secure communications and Good Clinical Laboratory Practice Standards on the World-Wide Web
|
Schuette, R.Wade |
|
1997 |
18 |
3S1 |
p. S91- 1 p. |
artikel |
3 |
87 A data warehousing approach to support clinical trials research
|
Niland, Joyce C. |
|
1997 |
18 |
3S1 |
p. S95- 1 p. |
artikel |
4 |
77 Adjusting survival analysis for the presence of nonadjudicated potential study events
|
Cook, Thomas |
|
1997 |
18 |
3S1 |
p. S89- 1 p. |
artikel |
5 |
08 A global measure of influence for the Cox regression model
|
Barlow, William E. |
|
1997 |
18 |
3S1 |
p. S45-S46 2 p. |
artikel |
6 |
34 A mixture model for the chance to conceive in subfertile couples based on the beta-distribution
|
Eijkemans, M.J.C. |
|
1997 |
18 |
3S1 |
p. S61-S62 2 p. |
artikel |
7 |
98 Analysis of data from longitudinal clinical trials with drop-outs
|
Jansson, Gary |
|
1997 |
18 |
3S1 |
p. S102-S103 2 p. |
artikel |
8 |
89 An automatic coding system
|
Maupas, Jean |
|
1997 |
18 |
3S1 |
p. S96- 1 p. |
artikel |
9 |
29 A new bayesian design for phase I cancer clinical trials
|
Toledano, Alicia Y. |
|
1997 |
18 |
3S1 |
p. S58- 1 p. |
artikel |
10 |
62 A new randomization method for allocating subjects
|
Chappell, Rick |
|
1997 |
18 |
3S1 |
p. S79-S80 2 p. |
artikel |
11 |
84 An innovative approach to clinical trial conduction using internet
|
DeRosa, M. |
|
1997 |
18 |
3S1 |
p. S93- 1 p. |
artikel |
12 |
52 Application of gee procedures for sample size calculations in repeated measures experiments
|
Rochon, James |
|
1997 |
18 |
3S1 |
p. S73- 1 p. |
artikel |
13 |
11 Approaches to using predicted values in randomized Clinical Trials
|
Goedhart, Dick |
|
1997 |
18 |
3S1 |
p. S47-S48 2 p. |
artikel |
14 |
24 A proportional odds random effects model for repeated ordered responses
|
Santos, Dirley Moreira Dos |
|
1997 |
18 |
3S1 |
p. S55- 1 p. |
artikel |
15 |
17 A review and assessment of the participant recruitment strategies employed in the NSABP Breast Cancer Prevention Trial
|
Cronin, Walter M. |
|
1997 |
18 |
3S1 |
p. S51- 1 p. |
artikel |
16 |
109 A sequential design for studies with repeated measures on multiple outcomes
|
Leroux, Brian G. |
|
1997 |
18 |
3S1 |
p. S109- 1 p. |
artikel |
17 |
110 A three-armed equivalence study
|
Lange, S. |
|
1997 |
18 |
3S1 |
p. S109-S110 2 p. |
artikel |
18 |
13 A unified family of group sequential designs
|
Emerson, Scott S. |
|
1997 |
18 |
3S1 |
p. S49- 1 p. |
artikel |
19 |
Author Index
|
|
|
1997 |
18 |
3S1 |
p. S191-S211 21 p. |
artikel |
20 |
26 Bayesian decision procedures for phase I dose-escalation studies
|
Whitehead, John |
|
1997 |
18 |
3S1 |
p. S56- 1 p. |
artikel |
21 |
32 Building multivariable prognostic models: Transformation of the predictors using fractional polynomials
|
Sauerbrei, Willi |
|
1997 |
18 |
3S1 |
p. S60- 1 p. |
artikel |
22 |
Calender of program
|
|
|
1997 |
18 |
3S1 |
p. S4-S39 36 p. |
artikel |
23 |
49 Case-control design using multivariate generalization of the cox model: Application to central catheters related bacteremia
|
Mahe, Cédric |
|
1997 |
18 |
3S1 |
p. S71- 1 p. |
artikel |
24 |
18 Challenges faced in recruiting patients from primary care practices into a behavioral modification trial
|
Margitić, Susan |
|
1997 |
18 |
3S1 |
p. S52- 1 p. |
artikel |
25 |
74 Challenges of adverse experience reporting, coding and analysis: areas for improvement
|
Krause-Steinrauf, Heidi |
|
1997 |
18 |
3S1 |
p. S87-S88 2 p. |
artikel |
26 |
41 Challenges of the prevention of events with angiotensin converting enzyme inhibition trial
|
|
|
1997 |
18 |
3S1 |
p. S66- 1 p. |
artikel |
27 |
55 Changes in sample size and length of follow-up to maintain power in the cabg patch trial
|
Bigger, J.T. |
|
1997 |
18 |
3S1 |
p. S75- 1 p. |
artikel |
28 |
70 Choosing an appropriate dichotomous effect measure for meta-analysis: Empirical evidence of the appropriateness of the odds ratio and relative risk
|
Deeks, J.J. |
|
1997 |
18 |
3S1 |
p. S84-S85 2 p. |
artikel |
29 |
14 Clinical equivalence test and confidence interval for the difference in proportions for the paired-sample design
|
Tango, Toshiro |
|
1997 |
18 |
3S1 |
p. S49-S50 2 p. |
artikel |
30 |
23 Clinically relevant analyses of diary card data in asthma studies
|
Mander, Adrian |
|
1997 |
18 |
3S1 |
p. S55- 1 p. |
artikel |
31 |
42 Clinical monitoring of children's development in the dietary intervention study in children
|
Barton, Bruce |
|
1997 |
18 |
3S1 |
p. S66-S67 2 p. |
artikel |
32 |
63 Clinical trials with dichotomous endpoints: Should we correct for baseline characteristics?
|
Steyerberg, E.W. |
|
1997 |
18 |
3S1 |
p. S80- 1 p. |
artikel |
33 |
30 Comparison of competing parametric survival models — a bayesian perspective
|
Abrams, Keith R. |
|
1997 |
18 |
3S1 |
p. S59- 1 p. |
artikel |
34 |
43 Comparison of routine and survey data for the evaluation of a community randomized trial: A case study
|
Sterne, J.A.C. |
|
1997 |
18 |
3S1 |
p. S67- 1 p. |
artikel |
35 |
88 Computerized intervention tracking system for data management and protocol adherence
|
Hogan, Patricia |
|
1997 |
18 |
3S1 |
p. S95-S96 2 p. |
artikel |
36 |
108 Conditional power for weighted log-rank statistics with covariate adjustments
|
Yao, Qing |
|
1997 |
18 |
3S1 |
p. S108-S109 2 p. |
artikel |
37 |
78 Controlling survival comparisons to reflect subgroup analyses in phase III clinical trials
|
Bryant, John |
|
1997 |
18 |
3S1 |
p. S90- 1 p. |
artikel |
38 |
104 Design of the economic evaluation of the sortie trial
|
Mauldin, Patrick D. |
|
1997 |
18 |
3S1 |
p. S106- 1 p. |
artikel |
39 |
91 Design of the randomized evaluation of strategies for left ventricular dysfunction (resolvd) pilot study: A trial of combination neurohormonal blockade in patients with congestive heart failure
|
Tsuyuki, Ross T. |
|
1997 |
18 |
3S1 |
p. S98- 1 p. |
artikel |
40 |
10 Development of a clinical prediction model for an ordinal diagnostic outcome
|
Harrell Jr., Frank E. |
|
1997 |
18 |
3S1 |
p. S47- 1 p. |
artikel |
41 |
106 Early termination of a clinical trial when there is evidence that the treatment will ultimately not prove beneficial: protocol b-14 of the national surgical adjuvant breast and bowel project
|
Dignam, James |
|
1997 |
18 |
3S1 |
p. S107-S108 2 p. |
artikel |
42 |
71 EFfects of double data entry vs. single data entry as employed during a large multicenter perinatal clinical trial
|
Weston, Julie |
|
1997 |
18 |
3S1 |
p. S85- 1 p. |
artikel |
43 |
28 Empirical bayes methods in the annual quality comparison and ranking of dutch gynecological centres
|
Brand, Ronald |
|
1997 |
18 |
3S1 |
p. S57-S58 2 p. |
artikel |
44 |
16 Enrollment of women of childbearing potential in a NIH-sponsored clinical trial
|
Mickel, Mary |
|
1997 |
18 |
3S1 |
p. S51- 1 p. |
artikel |
45 |
25 Estimating the parameters of a random effects logistic model with the Nonparametric Maximum Likelihood Method (NPML)
|
Mesnil, Florence |
|
1997 |
18 |
3S1 |
p. S56- 1 p. |
artikel |
46 |
56 Ethics and practice: Alternative designs for phase III Randomized clinical trials
|
Rosenberger, William V. |
|
1997 |
18 |
3S1 |
p. S76- 1 p. |
artikel |
47 |
96 Evaluation of predictors and impact of losses to follow-up in the domain of hiv infection
|
Ioannidis, John P.A. |
|
1997 |
18 |
3S1 |
p. S101-S102 2 p. |
artikel |
48 |
105 Evaluation of responsiveness of health scales for outcome measurement in clinical trials
|
Holle, Rolf |
|
1997 |
18 |
3S1 |
p. S107- 1 p. |
artikel |
49 |
94 Evaluation of standard treatment strategies in a large, multicenter trial: Design issues
|
Rosenberg, Yves |
|
1997 |
18 |
3S1 |
p. S100- 1 p. |
artikel |
50 |
60 Experiences of a biostatistician on a research ethics committee
|
Vail, Andy |
|
1997 |
18 |
3S1 |
p. S78- 1 p. |
artikel |
51 |
66 Explaining heterogeneity in meta-analysis: A comparison of methods
|
Thompson, Simon G. |
|
1997 |
18 |
3S1 |
p. S82- 1 p. |
artikel |
52 |
72 Factors that affect timely submission of forms to a data management center
|
Lancaster, Scott |
|
1997 |
18 |
3S1 |
p. S86- 1 p. |
artikel |
53 |
107 Global monitoring of prevention trials: the breast cancer prevention trial (bcpt) experience
|
Anderson, Stewart J. |
|
1997 |
18 |
3S1 |
p. S108- 1 p. |
artikel |
54 |
64 Global tests for multiple endpoints in clinical trials
|
McDermott, Michael P. |
|
1997 |
18 |
3S1 |
p. S81- 1 p. |
artikel |
55 |
100 Group comparisons involving missing data in clinical trials: use of observed versus imputed data
|
Miller, Michael E. |
|
1997 |
18 |
3S1 |
p. S103-S104 2 p. |
artikel |
56 |
58 How informed is ‘informed’ consent? Participants' responses to random allocation of critically ill neonates to alternative treatments in the UK collaboration ECMO trial
|
Elbourne, D. |
|
1997 |
18 |
3S1 |
p. S77- 1 p. |
artikel |
57 |
35 How to perform the two-stage analysis of cross-over trials if you can't be persuaded not to
|
Senn, Stephen |
|
1997 |
18 |
3S1 |
p. S62- 1 p. |
artikel |
58 |
44 Identification of strategies to ensure patients continue taking study medication — results from the lipid study
|
|
|
1997 |
18 |
3S1 |
p. S68- 1 p. |
artikel |
59 |
20 Implementing a centralized protocol-patient accrual system — short and long term benefits
|
Van-Tull, Bonita |
|
1997 |
18 |
3S1 |
p. S53- 1 p. |
artikel |
60 |
69 Inclusion of both patient level and study-level covariates in a meta-analysis
|
Higgins, Julian P.T. |
|
1997 |
18 |
3S1 |
p. S84- 1 p. |
artikel |
61 |
101 Incorporating a quality of life assessment into an ongoing multi-center clinical trial: problems and recommendations
|
|
|
1997 |
18 |
3S1 |
p. S104- 1 p. |
artikel |
62 |
86 In-house code generators: A rad new concept
|
Terrell, J.Timothy |
|
1997 |
18 |
3S1 |
p. S94- 1 p. |
artikel |
63 |
82 Internet security in clinical trial data management systems
|
Martin, Jeffrey P. |
|
1997 |
18 |
3S1 |
p. S92- 1 p. |
artikel |
64 |
95 Issues in running a sequential randomized trial in pressure sore prevention
|
Brown, Julia |
|
1997 |
18 |
3S1 |
p. S101- 1 p. |
artikel |
65 |
93 Issues in the design of a multicenter trial comparing radiation therapy to expandable esophageal stents for patients with advanced unresectable esophageal cancer
|
Redmond, Carol K. |
|
1997 |
18 |
3S1 |
p. S99-S100 2 p. |
artikel |
66 |
97 Late visit reports to ensure patient retention
|
Zadnik, Karla |
|
1997 |
18 |
3S1 |
p. S102- 1 p. |
artikel |
67 |
Letter from the president
|
|
|
1997 |
18 |
3S1 |
p. S1- 1 p. |
artikel |
68 |
79 Link-based models for survival data with random interval and continuous time censoring
|
Younes, Naji |
|
1997 |
18 |
3S1 |
p. S90-S91 2 p. |
artikel |
69 |
05 Local data management in cancer clinical trials
|
Haining, Shona A. |
|
1997 |
18 |
3S1 |
p. S43-S44 2 p. |
artikel |
70 |
46 Logistic regression upon a continuous covariate with a changepoint
|
Signorini, David F. |
|
1997 |
18 |
3S1 |
p. S69- 1 p. |
artikel |
71 |
22 Longitudinal analysis of sinusoidality of time-qualified data
|
Shyr, Yu |
|
1997 |
18 |
3S1 |
p. S54- 1 p. |
artikel |
72 |
67 Measures of heterogeneity in meta-analysis
|
Seagroatt, Valerie |
|
1997 |
18 |
3S1 |
p. S82-S83 2 p. |
artikel |
73 |
04 Measuring workload of cancer clinical trials: A multi-centre study by the clinical research associates (CRA) committee of the national cancer institute of Canada clinical trials group (NCIC CTG)
|
Roche, Kathryn |
|
1997 |
18 |
3S1 |
p. S43- 1 p. |
artikel |
74 |
76 Modeling survival data with multiple ordinal outcomes
|
Berridge, Damon Mark |
|
1997 |
18 |
3S1 |
p. S89- 1 p. |
artikel |
75 |
07 On the choice of regression model for censored Survival data
|
Stare, Janez |
|
1997 |
18 |
3S1 |
p. S45- 1 p. |
artikel |
76 |
31 Optimal design in nonlinear regression random effects models — application in population pharmacokinetics
|
Mentré, France |
|
1997 |
18 |
3S1 |
p. S59-S60 2 p. |
artikel |
77 |
15 Optimization of testing times and critical values in sequential equivalence testing
|
Müller, Hans-Helge |
|
1997 |
18 |
3S1 |
p. S50- 1 p. |
artikel |
78 |
33 Overfit in logistic regression
|
Schemper, Michael |
|
1997 |
18 |
3S1 |
p. S61- 1 p. |
artikel |
79 |
P97 Accidental exposure of central laboratory personnel to potentially infectious clinical trial specimens. What are the issues?
|
Wasilauskas, Carol H. |
|
1997 |
18 |
3S1 |
p. S171- 1 p. |
artikel |
80 |
P91 A comparison of sample size methods for survival studies
|
Benner, Axel |
|
1997 |
18 |
3S1 |
p. S167- 1 p. |
artikel |
81 |
P65 A data management system for assessing health outcomes in an inner city managed care asthma patient population
|
Levenson, Suzette M. |
|
1997 |
18 |
3S1 |
p. S150- 1 p. |
artikel |
82 |
P05 Adequacy of the proportional hazards model using lin, wei and ying plots
|
O'Quigley, John |
|
1997 |
18 |
3S1 |
p. S113- 1 p. |
artikel |
83 |
P49 Age at any birth and breast cancer risk
|
Robertson, Chris |
|
1997 |
18 |
3S1 |
p. S140- 1 p. |
artikel |
84 |
P121 Aggregate patient data meta-analyses with time-to-event endpoints: An example from surgery
|
Williamson, Paula |
|
1997 |
18 |
3S1 |
p. S184-S185 2 p. |
artikel |
85 |
P88 A multi-state markov process model for quality of life and survival in large heart failure clinical trials
|
Charlesworth, A. |
|
1997 |
18 |
3S1 |
p. S165- 1 p. |
artikel |
86 |
P68 An alternative to the customary reporting of common toxicity criteria
|
Anderson, Stewart |
|
1997 |
18 |
3S1 |
p. S152- 1 p. |
artikel |
87 |
P106 Analysis of ordered categorical data: Towards a stratified model
|
Savaluny, Elly |
|
1997 |
18 |
3S1 |
p. S176- 1 p. |
artikel |
88 |
P47 Analysis of risk factors for adverse drug reaction in pharmaco-epidemiologic case control studies
|
Schäfer, Helmut |
|
1997 |
18 |
3S1 |
p. S139- 1 p. |
artikel |
89 |
P104 Analysis of the titration procedure for warfarin in the post coronary artery bypass graft (POST CABG) clinical trial
|
Canner, Joseph |
|
1997 |
18 |
3S1 |
p. S175- 1 p. |
artikel |
90 |
P31 analyzing chemosensitivity assays for Acute Myelogenic Leukemia
|
Simpson, P.M. |
|
1997 |
18 |
3S1 |
p. S129- 1 p. |
artikel |
91 |
P52 Analyzing compliance in clinical trials: A sensitive point
|
Goetghebeur, Els |
|
1997 |
18 |
3S1 |
p. S142- 1 p. |
artikel |
92 |
P06 Analyzing the structure of the hazard function
|
Mocks, Joachim |
|
1997 |
18 |
3S1 |
p. S114- 1 p. |
artikel |
93 |
P61 An automated clinical center payment system
|
Corky, Scott |
|
1997 |
18 |
3S1 |
p. S147- 1 p. |
artikel |
94 |
P02 An investigation of the effect of covariate adjustment in a sequential clinical trial
|
Sahdra, M. |
|
1997 |
18 |
3S1 |
p. S111-S112 2 p. |
artikel |
95 |
P64 An optimal network access in a patient registration system
|
Nibhanupudi, Mohan |
|
1997 |
18 |
3S1 |
p. S149- 1 p. |
artikel |
96 |
P99 Application of “design”s functions to build multivariate models for predicting coronary artery disease
|
|
|
1997 |
18 |
3S1 |
p. S172- 1 p. |
artikel |
97 |
P24 a quality assurance monitoring system: The national cancer institute clinical cooperative oncology group experience
|
Smith, Gary |
|
1997 |
18 |
3S1 |
p. S125- 1 p. |
artikel |
98 |
P32 a quality control analysis to be used in determining whether or not the enzyme-linked immunosorbent assay is in control
|
Johnson, Paul |
|
1997 |
18 |
3S1 |
p. S130- 1 p. |
artikel |
99 |
P15 A quantitative protocol evaluation system
|
Herson, Jay |
|
1997 |
18 |
3S1 |
p. S119- 1 p. |
artikel |
100 |
P125 Are patients in a clinical trial representative?
|
Stead, Maxine |
|
1997 |
18 |
3S1 |
p. S187- 1 p. |
artikel |
101 |
P46 Assessing the effects of treatment in observational studies: Adjusting for disease severity
|
Sabin, Caroline A. |
|
1997 |
18 |
3S1 |
p. S138-S139 2 p. |
artikel |
102 |
P40 Assessing the risk of severe infectious disease when immunosuppressive drugs are administered during the study period
|
Heinzl, Harald |
|
1997 |
18 |
3S1 |
p. S134-S135 2 p. |
artikel |
103 |
P22 assessment of data quality in an nihsponsored multicenter clinical trial: The hemodialysis (HEMO) study
|
|
|
1997 |
18 |
3S1 |
p. S123-S124 2 p. |
artikel |
104 |
P53 Capture-recapture with two sources: Controlling for covariates
|
Tilling, K. |
|
1997 |
18 |
3S1 |
p. S142-S143 2 p. |
artikel |
105 |
P75 Challenges in implementing a telephone touch-tone randomization system in the primary care setting
|
Anthony, Susan |
|
1997 |
18 |
3S1 |
p. S156-S157 2 p. |
artikel |
106 |
P83 Cohort maintenance in the NHLBI growth and health study (NGHS)
|
Similo, Shari |
|
1997 |
18 |
3S1 |
p. S161-S162 2 p. |
artikel |
107 |
P116 Comparing statistical methods in meta-analyzing pooled data sets
|
Scheuchenpflug, Thomas |
|
1997 |
18 |
3S1 |
p. S181-S182 2 p. |
artikel |
108 |
P108 Comparing structures among groups by latent class analysis: An application of cognitive impairment scale
|
Lin, Ting Hsiang |
|
1997 |
18 |
3S1 |
p. S177-S178 2 p. |
artikel |
109 |
P39 Comparing two approaches for analyzing data with clumping at zero
|
Chang, Bei-Hung |
|
1997 |
18 |
3S1 |
p. S134- 1 p. |
artikel |
110 |
P130 Comparison between univariate and multivariate prognostic index to evaluate treatment efficacy in subgroups of patient at different risks of death. Data from a systematic overview
|
Santoro, Luigi |
|
1997 |
18 |
3S1 |
p. S190- 1 p. |
artikel |
111 |
P17 Comparison of medical record review with prospective data collection in randomized trials
|
Rajab, Mohammad H. |
|
1997 |
18 |
3S1 |
p. S120- 1 p. |
artikel |
112 |
P19 Comparison of participants and non-participants in a clinical trial of funguria
|
|
|
1997 |
18 |
3S1 |
p. S121- 1 p. |
artikel |
113 |
P73 Comparison of the accuracy of centralized double key data entry and single key interactive data entry
|
Ellis, Nancy |
|
1997 |
18 |
3S1 |
p. S155- 1 p. |
artikel |
114 |
P79 Compliance with qol assessment in a multicentre international breast cancer trial
|
Olschewski, Manfred |
|
1997 |
18 |
3S1 |
p. S159- 1 p. |
artikel |
115 |
P42 Components of chance-corrected agreement in the assessment of gastritis: Practical implications
|
Tinelli, Carmine |
|
1997 |
18 |
3S1 |
p. S136- 1 p. |
artikel |
116 |
P82 Confidence intervals for cost-effectiveness ratios: The use of bootstrapping
|
Campbell, Marion K. |
|
1997 |
18 |
3S1 |
p. S161- 1 p. |
artikel |
117 |
P29 Considering the patient's quality of life in a bayesian clinical trial design
|
Ballas, Dália |
|
1997 |
18 |
3S1 |
p. S128- 1 p. |
artikel |
118 |
P119 Construction of height and weight growth charts for iran from hierarchically structured data; With an investigation of appropriate statistical methods
|
Hosseini, Mostafa |
|
1997 |
18 |
3S1 |
p. S183-S184 2 p. |
artikel |
119 |
P123 Contradictory results from consecutive clinical trials: A cautious approach to explanations
|
|
|
1997 |
18 |
3S1 |
p. S186- 1 p. |
artikel |
120 |
P54 Controversial role of age as a prognostic factor in multiple myeloma
|
Klersy, Catherine |
|
1997 |
18 |
3S1 |
p. S143- 1 p. |
artikel |
121 |
P67 Data form entry using internet tools: The matrix system
|
Echement, Deborah A. |
|
1997 |
18 |
3S1 |
p. S151- 1 p. |
artikel |
122 |
P70 Data management and analytic support for an international individual patient data meta-analysis (IPD-MA)
|
Owen, Walter |
|
1997 |
18 |
3S1 |
p. S153- 1 p. |
artikel |
123 |
P71 Data management aspects of a systematic overview of individual data from 100,000 patients in randomized trials
|
Santoro, Eugenio |
|
1997 |
18 |
3S1 |
p. S154- 1 p. |
artikel |
124 |
P74 Data operations management with clinical datafax: The prostate cancer prevention trial (PCPT) experience
|
Ryan, Anne M. |
|
1997 |
18 |
3S1 |
p. S156- 1 p. |
artikel |
125 |
P21 data quality monitoring in a collaborative multi-center study: the interstitial cystitis data base (ICDB) study
|
Matthews, Yvonne L. |
|
1997 |
18 |
3S1 |
p. S123- 1 p. |
artikel |
126 |
P59 Design and implementation of a clinical research database in client/server architecture
|
Wu, Daniel |
|
1997 |
18 |
3S1 |
p. S146- 1 p. |
artikel |
127 |
P04 Detecting outliers by the grand tour
|
Bartkowiak, Anna |
|
1997 |
18 |
3S1 |
p. S113- 1 p. |
artikel |
128 |
P114 Development of a protocol office: A concept for the 1990's
|
Flaherty, Sandra |
|
1997 |
18 |
3S1 |
p. S180-S181 2 p. |
artikel |
129 |
P07 Effect of a non-susceptible fraction on standard survival analysis methods
|
Schnell, Daniel J. |
|
1997 |
18 |
3S1 |
p. S114- 1 p. |
artikel |
130 |
P57 Electronic systems for handling adverse event reports
|
Wong, Kenneth |
|
1997 |
18 |
3S1 |
p. S145- 1 p. |
artikel |
131 |
73 Pen-based remote data entry system in a multicenter clinical trial
|
Salvi, Junca |
|
1997 |
18 |
3S1 |
p. S86-S87 2 p. |
artikel |
132 |
P94 Establishing a system for prospective registration of human subjects participating in research studies at a comprehensive cancer center
|
Houston, Collette |
|
1997 |
18 |
3S1 |
p. S169- 1 p. |
artikel |
133 |
P93 Establishing the ethics of randomization in breast cancer trials
|
Abrams, Keith R. |
|
1997 |
18 |
3S1 |
p. S168-S169 2 p. |
artikel |
134 |
P01 Estimation in group sequential designs using simulated estimating equations
|
LeBlanc, Michael |
|
1997 |
18 |
3S1 |
p. S111- 1 p. |
artikel |
135 |
P11 Evaluation of a two-phase enrollment design: Experience of the age-related eye disease study (AREDS)
|
|
|
1997 |
18 |
3S1 |
p. S116-S117 2 p. |
artikel |
136 |
P09 Evaluation of the bias in using the time to the ferst event in the analysis of clinical trials of atrial fibrillation
|
Rose, M.S. |
|
1997 |
18 |
3S1 |
p. S115- 1 p. |
artikel |
137 |
P03 Graphical presentation of clinical trials results
|
Spino, Cathie |
|
1997 |
18 |
3S1 |
p. S112- 1 p. |
artikel |
138 |
P72 Hands on user training following a clinical research database upgrade
|
Marks, Linda D. |
|
1997 |
18 |
3S1 |
p. S154-S155 2 p. |
artikel |
139 |
P20 Huge variability in data quality exists according to country
|
Tardiff, Barbara E. |
|
1997 |
18 |
3S1 |
p. S122- 1 p. |
artikel |
140 |
P95 Human subjects review in long-term prevention trials: Recommendations from the caret experience
|
Boyle, M.Margaret |
|
1997 |
18 |
3S1 |
p. S170- 1 p. |
artikel |
141 |
P112 Identification of neonatal hearing impairment: Study design
|
Fletcher, Kristin A. |
|
1997 |
18 |
3S1 |
p. S179-S180 2 p. |
artikel |
142 |
P13 Identifying the effect of the learning curve in clinical trials
|
Ramsay, Craig |
|
1997 |
18 |
3S1 |
p. S118- 1 p. |
artikel |
143 |
P80 Identifying the types of missingness in longitudinal quality of life data from clinical trials
|
Bacchi, Marisa |
|
1997 |
18 |
3S1 |
p. S159-S160 2 p. |
artikel |
144 |
45 Pill counting and attainment of blood pressure goals in the african american study of kidney disease and hypertension (AASK)
|
Greene, Paul |
|
1997 |
18 |
3S1 |
p. S68-S69 2 p. |
artikel |
145 |
P96 Impact of equipoise, treatment presentation and severity of disease on informed consent to a randomized clinical trial a randomized trial in health subjects
|
Gallo, C. |
|
1997 |
18 |
3S1 |
p. S170-S171 2 p. |
artikel |
146 |
P92 Impact of fixed and stochastic selection at entry on regression to the mean and study power: Application to recurrent events
|
McMahon, Robert P. |
|
1997 |
18 |
3S1 |
p. S168- 1 p. |
artikel |
147 |
P77 Impact of trials with null number of events in meta-analysis
|
Cucherat, Michel |
|
1997 |
18 |
3S1 |
p. S158- 1 p. |
artikel |
148 |
P69 Improving compliance — the administration of quality of life questionnaires within cancer clinical trials
|
Poulter, Karen |
|
1997 |
18 |
3S1 |
p. S152-S153 2 p. |
artikel |
149 |
P126 Including literature data in individual patient data meta-analyses for time-to-event endpoints
|
Collette, Laurence |
|
1997 |
18 |
3S1 |
p. S188- 1 p. |
artikel |
150 |
P100 Individualizing patient therapy
|
Senn, Stephen |
|
1997 |
18 |
3S1 |
p. S173- 1 p. |
artikel |
151 |
P120 Individual patient data meta-analyses for time-to-event outcomes: An example from epilepsy
|
Williamson, Paula |
|
1997 |
18 |
3S1 |
p. S184- 1 p. |
artikel |
152 |
P105 Insight in analgesic trials through pharmacokinetic/pharmacodynamic analysis and simulation
|
Mandema, Jaap W. |
|
1997 |
18 |
3S1 |
p. S175-S176 2 p. |
artikel |
153 |
P38 intention-to-treat and vaccine efficacy trials
|
Horne, Amelia Dale |
|
1997 |
18 |
3S1 |
p. S133- 1 p. |
artikel |
154 |
P51 Interaction of epidemic and individual heterogeneity on target populations of clinical trials
|
Ioannidis, John A. |
|
1997 |
18 |
3S1 |
p. S141- 1 p. |
artikel |
155 |
P18 Interest of cardiac natriuretic peptides for risk stratification in heart failure trials
|
Ahn, Syvlie |
|
1997 |
18 |
3S1 |
p. S120-S121 2 p. |
artikel |
156 |
P127 Inter-reviewer variation the validata experience
|
Strang, W.N. |
|
1997 |
18 |
3S1 |
p. S188-S189 2 p. |
artikel |
157 |
P113 Investigator-initiated clinical trials: What academicians need to know
|
Herr, Barbara E. |
|
1997 |
18 |
3S1 |
p. S180- 1 p. |
artikel |
158 |
P66 Is central adjudication necessary to avoid bias in clinical outcomes?
|
Pogue, Janice |
|
1997 |
18 |
3S1 |
p. S150-S151 2 p. |
artikel |
159 |
P101 Longitudinal binary data analysis of use of contraceptive barrier methods
|
Wong, Emelita |
|
1997 |
18 |
3S1 |
p. S173- 1 p. |
artikel |
160 |
P27 longitudinal modeling of medical research data with a bayesian belief network
|
Clarke, Ellis J. |
|
1997 |
18 |
3S1 |
p. S126-S127 2 p. |
artikel |
161 |
P89 Measurement of sociodemographic characteristics in chronic disorder populations and their relationship to quality of life
|
Sereika, S. |
|
1997 |
18 |
3S1 |
p. S166- 1 p. |
artikel |
162 |
P08 Numbers of events needed in comparing survival data to a standard population using the subjects-years method
|
Tu, Dongsheng |
|
1997 |
18 |
3S1 |
p. S115- 1 p. |
artikel |
163 |
09 Poisson regression direct adjustment comparison of lifetables
|
Lachin, John M. |
|
1997 |
18 |
3S1 |
p. S46- 1 p. |
artikel |
164 |
P28 optimal phase II trial size from decision theory
|
Hart, Augustinus A.M. |
|
1997 |
18 |
3S1 |
p. S127- 1 p. |
artikel |
165 |
P16 Optimizing the composing of weight-adjusted drug doses from preselected stock sizes
|
Kaplan, Howard L. |
|
1997 |
18 |
3S1 |
p. S119- 1 p. |
artikel |
166 |
53 Power comparisons among different number of categories under ordered polytomous logistic regression model
|
Jeong, Jong-Hyeon |
|
1997 |
18 |
3S1 |
p. S74- 1 p. |
artikel |
167 |
P25 Peace automated randomization and drug assignment system
|
|
|
1997 |
18 |
3S1 |
p. S125-S126 2 p. |
artikel |
168 |
P62 Pen-computer assisted personal interviewing in a follow-up study of cognitive disorders in an institutionalized elderly population
|
Junca, S. |
|
1997 |
18 |
3S1 |
p. S148- 1 p. |
artikel |
169 |
P60 Problems and solutions in running a large multi-centre, community-based study
|
|
|
1997 |
18 |
3S1 |
p. S147- 1 p. |
artikel |
170 |
P45 Prognostic modeling with the lasso: An empirical evaluation
|
Steyerberg, E.W. |
|
1997 |
18 |
3S1 |
p. S138- 1 p. |
artikel |
171 |
P98 Progression of carotid artery intima-media thickness predicts clinical coronary events
|
LaBree, Laurie |
|
1997 |
18 |
3S1 |
p. S172- 1 p. |
artikel |
172 |
P118 Prospective meta-analysis using individual patient data vs meta-analysis of published reports: The case of ace-inhibitors in myocardial infarction
|
Franzosi, Maria Grazia |
|
1997 |
18 |
3S1 |
p. S183- 1 p. |
artikel |
173 |
P111 Protocol enhancements for a study of alcohol-dependent patients
|
Cramer, Joyce |
|
1997 |
18 |
3S1 |
p. S179- 1 p. |
artikel |
174 |
P78 Pseudo-likelihood methods for general missing data mechanisms
|
Michiels, Bart |
|
1997 |
18 |
3S1 |
p. S158- 1 p. |
artikel |
175 |
P87 Q-Twist analyses of childhood cancer treatment regimens
|
Gelber, Shari |
|
1997 |
18 |
3S1 |
p. S164-S165 2 p. |
artikel |
176 |
P26 Quality control reporting for multi-center trials — a report from the cpcra
|
DuChene, Alain |
|
1997 |
18 |
3S1 |
p. S126- 1 p. |
artikel |
177 |
P50 Radiotherapy review in phase iii breast cancer clinical trials: Is there a need for the submission of portal films?
|
Bryant, John |
|
1997 |
18 |
3S1 |
p. S141- 1 p. |
artikel |
178 |
P14 Recurrent miscarriage study: How should data from women who do not become pregnant be handled?
|
Karrison, Theodore |
|
1997 |
18 |
3S1 |
p. S118-S119 2 p. |
artikel |
179 |
P63 Registers of clinical trials in the regulatory affairs process
|
Strang, W.N. |
|
1997 |
18 |
3S1 |
p. S148-S149 2 p. |
artikel |
180 |
P86 Revisions to the ncic ctg expanded common toxicity criteria (ECTC)1 — do these revisions facilitate collection of more meaningful toxicity data for cancer clinical trials?
|
Bennett, Katherine |
|
1997 |
18 |
3S1 |
p. S164- 1 p. |
artikel |
181 |
99 Propensity score techniques for estimating treatment effects in clinical trials with drop-outs
|
D'Agostino Jr., Ralph B. |
|
1997 |
18 |
3S1 |
p. S103- 1 p. |
artikel |
182 |
P55 Showing results of clinical trials
|
Sztaniszláv, Daniel |
|
1997 |
18 |
3S1 |
p. S144- 1 p. |
artikel |
183 |
P103 Since when does correlation imply valid substitution?
|
Simpson, P.M. |
|
1997 |
18 |
3S1 |
p. S174- 1 p. |
artikel |
184 |
P115 Software for exploration and modeling of meta-analyses
|
DuMouchel, William |
|
1997 |
18 |
3S1 |
p. S181- 1 p. |
artikel |
185 |
P36 stage migration in gastric cancer; its influence on survival
|
Hermans, J. |
|
1997 |
18 |
3S1 |
p. S132- 1 p. |
artikel |
186 |
P129 State-of-the-art in vision randomized controlled clinical trials
|
Scherer, Roberta W. |
|
1997 |
18 |
3S1 |
p. S189-S190 2 p. |
artikel |
187 |
P76 Statistical issues in systematic reviews of chronic diseases
|
Ashby, Deborah |
|
1997 |
18 |
3S1 |
p. S157- 1 p. |
artikel |
188 |
P117 Statistical issues in the meta-analysis of treatments for Alzheimer's disease
|
Whitehead, Anne |
|
1997 |
18 |
3S1 |
p. S182- 1 p. |
artikel |
189 |
P30 statistics and statisticians in european drug regulatory agencies: Unharmonized
|
Jones, David |
|
1997 |
18 |
3S1 |
p. S128-S129 2 p. |
artikel |
190 |
P107 Stochastic sensitivity analysis in markovian disease models
|
Mocks, Joachim |
|
1997 |
18 |
3S1 |
p. S177- 1 p. |
artikel |
191 |
P34 strategies for minimizing the effect of hormone assay variability on clinical trial results
|
Friedman, Lisa Aronson |
|
1997 |
18 |
3S1 |
p. S131- 1 p. |
artikel |
192 |
P124 Subjective pathology tumor grading: Impact on design and analysis of radiation therapy oncology group (RTOG) prostate trial 8531
|
Winter, Kathryn |
|
1997 |
18 |
3S1 |
p. S186-S187 2 p. |
artikel |
193 |
P84 Summarizing symptoms reported in daily diaries of women in the postmenopausal estrogen/progestins intervention (PEPI) trial
|
James, Margaret K. |
|
1997 |
18 |
3S1 |
p. S162- 1 p. |
artikel |
194 |
P48 Summary roc curve approach to assess the role of prognostic factors in liver cirrhosis
|
Morabito, Alberto |
|
1997 |
18 |
3S1 |
p. S140- 1 p. |
artikel |
195 |
P35 the analysis of transformed count data in clinical trials
|
Thompson, Bruce |
|
1997 |
18 |
3S1 |
p. S131-S132 2 p. |
artikel |
196 |
P44 The association between birth weight and change in blood pressure: Should we adjust for adult body mass index?
|
Hardy, Rebecca |
|
1997 |
18 |
3S1 |
p. S137- 1 p. |
artikel |
197 |
P58 The benefits of an intranet as a coordinating center tool for multi-center research projects: The Epidemiology Data Center Intranet
|
Martin, Jeffrey P. |
|
1997 |
18 |
3S1 |
p. S146- 1 p. |
artikel |
198 |
P12 The changing face of tamoxifen treatment and its influence on attom
|
Padmore, L. |
|
1997 |
18 |
3S1 |
p. S117- 1 p. |
artikel |
199 |
P56 The clinical trials group's computerized data checking system
|
Day, Andrew |
|
1997 |
18 |
3S1 |
p. S144-S145 2 p. |
artikel |
200 |
P10 The delicate balance of filter-coagulation and patient hemorrhage with renal replacement procedures: Multivariate failure time data analysis.
|
Zwinderman, Aeilko H. |
|
1997 |
18 |
3S1 |
p. S116- 1 p. |
artikel |
201 |
P43 The Design And Analysis Of A Study With Outcome Dependent Sampling
|
le Cessie, Saskia |
|
1997 |
18 |
3S1 |
p. S136-S137 2 p. |
artikel |
202 |
P90 The problem with a heuristic approach to sample size estimation for time-to-failure endpoints involving three or more treatment groups
|
Panzarella, Tony |
|
1997 |
18 |
3S1 |
p. S166-S167 2 p. |
artikel |
203 |
P128 The sensitivity and yield of hand and medline searching for controlled trials in us general medical journals
|
Reynolds, Matthew |
|
1997 |
18 |
3S1 |
p. S189- 1 p. |
artikel |
204 |
P110 The statistical analysis of the agreement between the qualitative and quantitative clinical trial diagnostic devices
|
Chiou, Wen-Jau |
|
1997 |
18 |
3S1 |
p. S178-S179 2 p. |
artikel |
205 |
P122 The thrombolysis in acute stroke-pooling project: A prospective meta-analysis on individual patient data
|
Boutitie, F. |
|
1997 |
18 |
3S1 |
p. S185- 1 p. |
artikel |
206 |
P37 time series in clinical trials when can they be pooled?
|
Dunstan, Frank |
|
1997 |
18 |
3S1 |
p. S132-S133 2 p. |
artikel |
207 |
P81 Towards a utility-based assessment for cancer patients: Reliability and validity of the UBQ-C(ancer) items
|
Martin, A.J. |
|
1997 |
18 |
3S1 |
p. S160- 1 p. |
artikel |
208 |
P102 Unbiased trapezoidal estimation of area under curve from time response data with multiplicative exponential structure
|
Jonsson, Robert |
|
1997 |
18 |
3S1 |
p. S174- 1 p. |
artikel |
209 |
P41 Use of corrected P-values in selecting optimal cutpoints for prognostic factor studies
|
Mazumdar, M. |
|
1997 |
18 |
3S1 |
p. S135- 1 p. |
artikel |
210 |
P33 use of genotyping in clinical trials
|
Wiklund, Kerstin |
|
1997 |
18 |
3S1 |
p. S130-S131 2 p. |
artikel |
211 |
P85 Use of physician investigators for outcome review in the hemodialysis (HEMO) study
|
|
|
1997 |
18 |
3S1 |
p. S163- 1 p. |
artikel |
212 |
P23 use of the world wide web for clinical monitoring in multicenter clinical trials
|
Schafer, Kimberly |
|
1997 |
18 |
3S1 |
p. S124- 1 p. |
artikel |
213 |
P109 Using cluster analysis to identify risk groups for asthma morbidity among inner-city children
|
Lynn, Henry |
|
1997 |
18 |
3S1 |
p. S178- 1 p. |
artikel |
214 |
75 Retrospective, descriptive study of timeliness of clinical events reporting in a national HIV community-based clinical trials network
|
Child, C.C. |
|
1997 |
18 |
3S1 |
p. S88- 1 p. |
artikel |
215 |
57 Risk communication strategies during an ongoing clinical trial: Protecting participant safety without causing unnecessary panic, the breast cancer prevention trial (BCPT) experience
|
Costantino, J.P. |
|
1997 |
18 |
3S1 |
p. S76-S77 2 p. |
artikel |
216 |
51 Sample size and design considerations for phase II clinical trials with correlated observations
|
Sargent, Daniel J. |
|
1997 |
18 |
3S1 |
p. S73- 1 p. |
artikel |
217 |
103 Sample size calculation for clinical trials: The role of economic significance
|
Campbell, Marion K. |
|
1997 |
18 |
3S1 |
p. S105-S106 2 p. |
artikel |
218 |
S40 Estimation of rate of change in longitudinal studies with attrition with application in hiv clinical trials
|
Toulomi, Giota |
|
1997 |
18 |
3S1 |
p. S65- 1 p. |
artikel |
219 |
47 Sex differences in treatment of acute myocardial infarction
|
Gardinale, E. |
|
1997 |
18 |
3S1 |
p. S70- 1 p. |
artikel |
220 |
61 Significance level at treatment allocation by means of minimization
|
Anderson, Harald |
|
1997 |
18 |
3S1 |
p. S79- 1 p. |
artikel |
221 |
S38 Joint estimation of the mean and overdispersion parameters of an overdispersed poisson distribution using quasi-likelihood
|
Bautista, Oliver M. |
|
1997 |
18 |
3S1 |
p. S64- 1 p. |
artikel |
222 |
S36 Multiple endpoints en trials en HIV infection
|
Walker, A.Sarah |
|
1997 |
18 |
3S1 |
p. S63- 1 p. |
artikel |
223 |
S37 Practical properties of some structural mean analyses of the effect of compliance in randomized trials
|
Lapp, Krista |
|
1997 |
18 |
3S1 |
p. S63-S64 2 p. |
artikel |
224 |
S39 Statistical analysis of circadian blood pressure utilizing mixed models with smoothing splines
|
MacDougall, James E. |
|
1997 |
18 |
3S1 |
p. S65- 1 p. |
artikel |
225 |
50 Statistical arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer
|
Schmoor, Claudia |
|
1997 |
18 |
3S1 |
p. S72- 1 p. |
artikel |
226 |
12 Statistical methods to assess prognosis and to help treatment decision
|
Ulm, K. |
|
1997 |
18 |
3S1 |
p. S48- 1 p. |
artikel |
227 |
80 Structural failure time models for causal inference in clinical trials
|
Loeys, Tom |
|
1997 |
18 |
3S1 |
p. S91- 1 p. |
artikel |
228 |
59 Subversion of allocation in a randomised controlled trial
|
Kennedy, Andrew |
|
1997 |
18 |
3S1 |
p. S77-S78 2 p. |
artikel |
229 |
03 Surrogate endpoints for the prophylactic treatment of tat1 bladder cancer: A combined analysis of eortc and mrc randomized clinical trials
|
|
|
1997 |
18 |
3S1 |
p. S42- 1 p. |
artikel |
230 |
01 Surrogate endpoints in clinical trials: Some statistical perspectives
|
Frison, Lars |
|
1997 |
18 |
3S1 |
p. S41- 1 p. |
artikel |
231 |
27 Testing superiority of a combination therapy using prior information on the component treatments
|
Farebrother, Joanna |
|
1997 |
18 |
3S1 |
p. S57- 1 p. |
artikel |
232 |
21 The analysis of complex patterns of longitudinal binary response in clinical trials
|
Thompson, Simon G. |
|
1997 |
18 |
3S1 |
p. S54- 1 p. |
artikel |
233 |
102 The analysis of repeated multivariate binary data: Application of hierarchical models to quality of life data
|
Beacon, Heather J. |
|
1997 |
18 |
3S1 |
p. S105- 1 p. |
artikel |
234 |
06 The Clinical Trials Training Program (CTTP) at Memorial Sloan-Kettering Cancer Center
|
Dean, Lorna K. |
|
1997 |
18 |
3S1 |
p. S44- 1 p. |
artikel |
235 |
48 The impact on prevalence of dementia in the oldest age groups of differential mortality patterns
|
McGee, M.A. |
|
1997 |
18 |
3S1 |
p. S70-S71 2 p. |
artikel |
236 |
54 The use of a sample size review in a head injury trial with ordered categorical responses
|
Bolland, Kim |
|
1997 |
18 |
3S1 |
p. S74-S75 2 p. |
artikel |
237 |
02 The validation of surrogate endpoints in randomized clinical trials
|
Molenberghs, Gert |
|
1997 |
18 |
3S1 |
p. S41-S42 2 p. |
artikel |
238 |
65 Treatment comparisons controlling for multiple testing
|
Brooks, Maria Mori |
|
1997 |
18 |
3S1 |
p. S81- 1 p. |
artikel |
239 |
90 Use of fax in data management software in a multicentered, multinational trial: Experience of the hope study
|
Bosch, Jackie |
|
1997 |
18 |
3S1 |
p. S97- 1 p. |
artikel |
240 |
19 Utility of the enrollment period in the Prostate Cancer Prevention Trial (PCPT)
|
Goodman, Phyllis J. |
|
1997 |
18 |
3S1 |
p. S52-S53 2 p. |
artikel |
241 |
83 Web databases: Oh what a tangled web we weave
|
Rushing, Scott |
|
1997 |
18 |
3S1 |
p. S92-S93 2 p. |
artikel |
242 |
85 Web development for clinical trials: It's not just for-programmers anymore
|
Bak, Sharon M. |
|
1997 |
18 |
3S1 |
p. S93-S94 2 p. |
artikel |
243 |
92 Women's health initiative memory study: A trial of the effect of estrogen therapy in preventing dementia
|
Melton, Beth |
|
1997 |
18 |
3S1 |
p. S99- 1 p. |
artikel |